Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis.
Carine MoeziniaValerie WongJames WatsonLydia NagibSandra Lopez GarcesSiyu ZhangBahja Ahmed AbdiFlorence NewtonDavid AbrahamRichard StrattonPublished in: Cells (2023)
Systemic sclerosis (SSc) is a multisystem connective tissue disease characterised by pathological processes involving autoimmunity, vasculopathy and resultant extensive skin and organ fibrosis. Recent studies have demonstrated activation and aberrant wound healing responses in the epithelial layer of the skin in this disease, implicating the epithelial keratinocytes as a source of pro-fibrotic and inflammatory mediators. In this paper, we investigated the role of Immunoglobulin G (IgG) autoantibodies directed against epithelial cells, as potential initiators and propagators of pathological keratocyte activation and the ensuing SSc fibrotic cascade. A keratinocyte cell-based ELISA is used to evaluate the binding of SSc IgG. SSc skin biopsies were stained by immunofluorescence for the presence of IgG in the keratinocyte layer. Moreover, IgG purified from SSc sera was evaluated for the potential to activate keratinocytes in tissue culture and to induce TLR2 and 3 signalling in reporter cell lines. We demonstrate enhanced binding of SSc IgG to keratinocytes and the activation of these cells leading to the release of IL-1α, representing a potential initiating pathway in this disease.
Keyphrases
- systemic sclerosis
- wound healing
- interstitial lung disease
- systemic lupus erythematosus
- soft tissue
- stem cells
- oxidative stress
- induced apoptosis
- immune response
- toll like receptor
- crispr cas
- single cell
- cell therapy
- rheumatoid arthritis
- human health
- cell proliferation
- mass spectrometry
- cell cycle arrest
- mesenchymal stem cells
- bone marrow
- monoclonal antibody
- nuclear factor